Back to REGN

REGENERON PHARMACEUTICALS, INC. Long-Term Debt 2010-2026 | REGN

Beta

What is long-term debt?

Long-term debt includes bonds, mortgages, and other borrowings with maturities greater than one year.

What is REGENERON PHARMACEUTICALS, INC.'s current long-term debt?

REGENERON PHARMACEUTICALS, INC. (REGN) annual long-term debt for 2025 was $1.99B, a 0.08% increase from 2024. REGENERON PHARMACEUTICALS, INC. long-term debt for the quarter ending March 31, 2026 was $1.99B.

What was REGENERON PHARMACEUTICALS, INC.'s long-term debt in 2024?

REGENERON PHARMACEUTICALS, INC. annual long-term debt for 2024 was $1.98B, a 0.08% increase from 2023.

What was REGENERON PHARMACEUTICALS, INC.'s long-term debt in 2023?

REGENERON PHARMACEUTICALS, INC. annual long-term debt for 2023 was $1.98B, a 0.08% increase from 2022.

What is REGENERON PHARMACEUTICALS, INC.'s 5-year long-term debt CAGR?

REGENERON PHARMACEUTICALS, INC. long-term debt grew at a compound annual growth rate (CAGR) of 0.07% from FY2020 to FY2025, going from $1.98B to $1.99B over 5 years.

Long-Term Debt History

Year-over-year comparison from 10-K annual reports

Key Statistics
Trend Direction
Stable
CAGR+0.1%
FY2020
$1.98B
→
FY2025
$1.99B
10111213141519202122232425
5 years selected
Long-Term Debt History
PeriodValueChangeSource
FY2025$1.99B+0.1%10-K
FY2024$1.98B+0.1%10-K
FY2023$1.98B+0.1%10-K
FY2022$1.98B+0.1%10-K
FY2021$1.98B+0.1%10-K
FY2020$1.98B-10-K
FY2019$0-10-K
FY2015$0-100.0%10-K
FY2014$146.8M-54.2%10-K
FY2013$320.3M+8.0%10-K
FY2012$296.5M+7.8%10-K
FY2011$275.0M-10-K
FY2010$0-10-K
Company: REGENERON PHARMACEUTICALS, INC.Ticker: REGNSector: HealthcareIndustry: Pharmaceutical PreparationsView company profile →